Pharma Journalist - Page 29 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AstraZeneca to Invest $2 Billion in Major Maryland Expansion

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to $2.37 Billion

EU Grants Conditional Approval for Roche’s One-Minute Subcutaneous Lunsumio in Follicular Lymphoma

Novartis to Build Major U.S. Manufacturing Hub in North Carolina

FDA Approves Expanded Dosing Options for Regeneron’s EYLEA HD in Retinal Diseases

Moderna Expands U.S. Manufacturing with New Onshore Drug Product Facility

Merck’s Two-Drug HIV Regimen Meets Phase 3 Trial Goals

EC Approves First Simponi Biosimilar Gobivaz in Europe

FDA Approves Arrowhead’s REDEMPLO, the First siRNA Therapy for Familial Chylomicronemia Syndrome

EU Approves First Subcutaneous Version of Keytruda for All Adult Indications